Abbreviated Magnetic Resonance Imaging vs Ultrasound Surveillance for Liver Cancer dETection in People at High Risk of Developing Liver Cancer

Inclusion Criteria: * • Participant is willing and able to give informed consent for participation in the study AND * All genders, aged 18 years or above AND * Eligible for HCC US surveillance in the opinion of the local investigators AND * Child Pugh score A or B AND * Diagnosed with liver cirrhosis due to ArLD, MASLD, chronic hepatitis C, chronic hepatitis B, genetic haemochromatosis AND * Have an annual risk of HCC of at least 3% as determined by the aMAP score OR * Participants with chronic liver disease (with or without cirrhosis) who had successful treatment for HCC, have not had a recurrence and have returned to 6 monthly surveillance with USS Exclusion Criteria: * • Contraindication to MRI * Known allergy / reaction to intravenous gadolinium contrast * Prisoners * Pregnancy or breast feeding * Previous liver transplant * Participants who are known to have indeterminate liver nodules on prior imaging requiring ongoing follow-up with MRI or CT * Previous HCC treated with curative intent and still being followed up with CT or MRI with contrast for possible recurrence * Estimated glomerular filtration rate of \<30 ml/min/1.73m2 * Participant is on haemodialysis * Participants who are unlikely to comply with the study procedures in the opinion of the local investigator * In the view of the clinician, if the participant has a co-morbidity likely to lead to death within the following 12 months